By reducing appetite and calorie intake, they make fat loss more achievable but they can also increase the risk of losing muscle if protein intake and resistance training are not prioritized
There was no evidence demonstrating other significant safety issue differences (e.g., serious AEs) between GLP-1RA plus SGLT2i combination therapy and either GLP-1RA or SGLT2i monotherapy [59]
Recent real-world data from a three-year analysis by Prime Therapeutics show that only 37% of people using GLP-1 drugs for obesity remain on them longer than one year, with adherence plunging to just 8% by year three
Fatty foods are harder to digest and remain in your stomach even longer, triggering bloating and nausea
Oxidative stress can be caused by elevated levels of sugar in the blood (hyperglycemia), as well as insulin deficiency or resistance
Unlike glycolysis, the PPP produces no ATP